OakChart

Shoulder Innovations Inc

SIHealthcare·Medical Devices·USA·Small·NYSE·Nov 11 • 11:35 AM ET

21.63-0.30 (-1.37%)
2026-11-11 17:36 CET
Market cap
458.83 USD m
Revenue, TTM
64.49 USD m
Net income, TTM
-33.35 USD m
Free cash flow, TTM
-43.19 USD m
EPS diluted, TTM
-1.61
P/E
-
Compare

Price

SI against its 20, 50 and 200-day averages
2050200beatmiss
15.0020.0025.00383K767KMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26SIclose 21.6320-day 19.8050-day 19.05200-day 17.2621.6352w high

12.1% under the 52-week high of 24.60 on 29 Jul 2026. 52-week low 10.92 on 11 Nov 2025. Last 15 sessions, 19.7% high to low

Profile

SI
52-week range, 78% of the way up
10.9224.59

Shoulder Innovations, Inc. engages in the provision of medical devices. It focuses on transforming the shoulder surgical care market. It also offers advanced implant systems for shoulder arthroplasty. The company was founded by Stephen B. Gunther and Michael DeVries in 2009 and is headquartered in Grand Rapids, MI.

IndexRUT
Employees75
IPOJul 31, 2025
Beta-1.61
ATR, 14d1.23
Rel volume1.64
Short float6.17%
Insider own45.32%
Inst own41.26%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap452.55M
Enterprise Value375.10M
Income-33.35M
Sales64.49M
Book/sh5.66
Cash/sh4.41
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees75
IPOJul 31, 2025

Ratios

P/E-
Forward P/E-
PEG-
P/S7.02
P/B3.82
P/C4.90
P/FCF-
EV/EBITDA-
EV/Sales5.82
Quick Ratio8.69
Current Ratio10.68
Debt/Eq0.13
LT Debt/Eq0.13
Option/ShortNo / Yes

Earnings

EPS (ttm)-1.61
EPS next Y-1.48
EPS next Q-0.45
EPS this Y63.76%
EPS next Y12.09%
EPS next 5Y34.44%
EPS past 3/5Y-75.53% -
Sales past 3/5Y56.68% -
EPS Y/Y TTM10.10%
Sales Y/Y TTM54.93%
EPS Q/Q20.26%
Sales Q/Q37.73%
EarningsNov 05 AMC
EPS/Sales Surpr.24.94% 2.42%

Ownership

Insider Own45.32%
Insider Trans-2.54%
Inst Own41.26%
Inst Trans4.04%
ROA-20.63%
ROE-25.05%
ROIC-25.03%
Gross Margin71.06%
Oper. Margin-54.44%
Profit Margin-51.72%
SMA209.23%
SMA5013.56%
SMA20025.29%
Trades-

Technical

Shs Outstand20.92M
Shs Float11.44M
Short Float6.17%
Short Ratio5.94
Short Interest0.71M
52W High24.59 -12.06%
52W Low10.92 98.08%
Volatility9.49% 6.26%
ATR (14)1.23
RSI (14)64.07
Beta-1.61
Rel Volume1.64
Avg Volume118.92K
Volume69,437

Performance

Perf Week2.95%
Perf Month19.70%
Perf Quarter12.48%
Perf Half Y59.87%
Perf YTD51.26%
Perf Year90.40%
Perf 3Y-
Perf 5Y-
Perf 10Y-
Recom1.00
Target Price27.00
Prev Close21.93
Price21.63
Change %-1.37%

Analyst ratings

latest 5 of 5
DateActionAnalystRating changeTargetImplied
Jul 28, 2026InitiatedUUBSBuy$27+24.8%
Aug 25, 2025InitiatedPPiper SandlerOverweight$18-16.8%
Aug 25, 2025InitiatedJJefferiesBuy$19-12.2%
Aug 25, 2025InitiatedGGoldmanBuy$20-7.5%
Aug 25, 2025InitiatedBBTIG ResearchBuy$23+6.3%

Peers

Mkt cap
TickerCompanyMkt cap
ENOVEnovis Corp1.63B
ZBHZimmer Biomet Holdings Inc20.11B
SYKStryker Corp120.77B
SNNSmith & Nephew plc ADR12.91B
CNMDConmed Corp1.52B
TMCITreace Medical Concepts Inc326.81M
KIDSOrthoPediatrics corp882.16M
SIBNSI-BONE Inc1.12B
OFIXOrthofix Medical Inc291.43M
ANIKAnika Therapeutics Inc186.06M

Insider trading

latest 14 of 33
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Ball Robert JosephCEO & Executive ChairmanOct 30 '26Option Exercise2.4866,757165,584447,581Nov 02 04:29 PM
Ball Robert JosephCEO & Executive ChairmanSep 14 '26Option Exercise2.1089,233187,282390,999Sep 14 08:23 PM
Ball Robert JosephCEO & Executive ChairmanSep 14 '26Sale18.4510,175187,706380,824Sep 14 08:23 PM
ROBERT BALLOfficerSep 14 '26Proposed Sale18.4510,175187,706Sep 14 04:19 PM
Gilde Healthcare Holding B.V.10% OwnerAug 26 '26Sale22.601,19627,0302,185,914Aug 28 04:11 PM
Gilde Healthcare Holding B.V.10% OwnerAug 21 '26Sale22.6120,516463,8672,187,791Aug 24 07:36 PM
Gilde Healthcare Holding B.V.10% OwnerAug 20 '26Sale22.603,90088,1402,208,307Aug 24 07:36 PM
Gilde Healthcare Holding B.V.10% OwnerAug 24 '26Sale22.6268115,4042,187,110Aug 24 07:36 PM
Ahearn Matthew FraserChief Operating OfficerAug 18 '26Sale20.9914,186297,704244,176Aug 18 04:47 PM
Ahearn Matthew FraserChief Operating OfficerAug 17 '26Sale20.108,314167,101258,362Aug 18 04:47 PM
MATTHEW AHEARNDirectorAug 17 '26Proposed Sale20.7322,500466,425Aug 17 04:48 PM
Gilde Healthcare Holding B.V.10% OwnerAug 05 '26Sale22.647,338166,1322,214,302Aug 07 04:12 PM
Gilde Healthcare Holding B.V.10% OwnerAug 06 '26Sale22.602,09547,3472,212,207Aug 07 04:12 PM
Gilde Healthcare Holding B.V.10% OwnerAug 04 '26Sale22.7799,8122,272,7192,221,640Aug 05 04:31 PM

Held by

AUM
TickerCompanyAUM
IWMiShares Russell 2000 Index FundAUM: 77.38B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWNiShares Russell 2000 Value ETFAUM: 14.10B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
IWCiShares Micro-Cap ETFAUM: 1.22B
AVSCAvantis U.S Small Cap Equity ETFAUM: 3.23B
VTWVVanguard Russell 2000 Value Index ETFAUM: 1.29B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
RSSLGlobal X Russell 2000 ETFAUM: 1.43B

News

latest 14 of 128
  • Shoulder Innovations Beats On The Bottom Line And Raises Again, But Sharp Growth Deceleration Shifts The Debate (Earnings Whispers)
  • Shoulder Innovations Reports Third Quarter 2026 Financial Results and Raises Full Year Outlook (PR Newswire)
  • Shoulder Innovations Faces A Seasonal Test Of Its Twice-Raised 2026 Outlook (Earnings Whispers)
  • Shoulder Innovations to Participate in Upcoming Investor Conferences (PR Newswire)
  • Can silver recover from its latest sell-off? UBS weighs in (Investing.com)
  • Loading…
  • Shoulder Innovations to Report Third Quarter 2026 Financial Results on November 5, 2026 (PR Newswire)
  • Shoulder Innovations Initiates Commercial Launch of the InSet Go (PR Newswire)
  • Shoulder Innovations Receives FDA 510(k) Clearance for N-22 Humeral Head and Initiates Full Commercial Launch (PR Newswire)
  • Shoulder Innovations Announces Exclusive Partnership with ALM Ortho to Introduce Bespoke Solution for Complex Shoulder Reconstruction Procedures (PR Newswire)
  • Shoulder Innovations Announces Settlement of Patent Litigation with Catalyst OrthoScience (PR Newswire)
  • Shoulder Innovations to Participate in the Morgan Stanley 24th Annual Healthcare Conference (PR Newswire)
  • UMH Properties and 4 More Stocks See Action From Activist Investors (Barrons.com) +7.80%
  • Silver could surge to $90 as investment demand takes over, Citi says (Investing.com)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-05-0.340-0.453-0.33916.1915.814
2026Q22026-08-06-0.490-0.459-0.49017.1816.564
2026Q12026-05-13-0.410-0.410-0.40616.7114.544
2025Q42026-03-10-0.380-0.385-0.37714.4212.794
2025Q32025-11-11-0.640-0.313-0.42411.769.875
2025Q22025-09-09-165.53-0.630-0.94311.0111.005
2025Q12025-05-28-0.239--0.23410.13--
2026Q4---0.450--19.334
2027Q1---0.395--20.722
2027Q2---0.505--21.512
2027Q3---0.350--20.862
2027Q4---0.440--24.242
2028Q1---0.220--27.131
2028Q2---0.336--26.731
2028Q3---0.217--26.341
2028Q4---0.224--29.551

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2025FY-4.650-2.136-2.23547.3245.57
2026FY--1.685--69.42
2027FY--1.482--88.39
2028FY--1.310--110.83
2029FY--1.700--129.3

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-0642119.3318.7020.02
2026Q4S2026-11-0340118.8417.7719.80
2026Q4S2026-10-2140118.9717.7719.80
2026Q4S2026-10-0943118.9717.7719.80
2026Q4S2026-09-2544019.0817.7719.80
2026Q4S2026-08-1944019.0917.8019.80
2026Q4S2026-08-0744019.0917.8019.80
2026Q4S2026-07-2840018.2916.9819.60
2026Q4S2026-07-2740318.2916.9819.60
2026Q4S2026-07-1430318.7317.3819.60
2026Q4S2026-06-0940318.5517.3819.60
2026Q4S2026-05-1440318.5517.3819.60
2026Q4S2026-05-0742018.8217.8919.80
2026Q4S2026-04-1042018.8017.8919.80

Estimate history

EPS, annual-0.635-0.784-1.957-1.6103
Period202320242025TTM
EPS, quarterly-0.204-0.19-0.234-0.943-0.424-0.377-0.406-0.49-0.338
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual19.27431.62347.31764.49
Period202320242025TTM
Sales, quarterly7.4548.72510.13211.01311.75614.41616.70817.17516.191
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual19.92319.92320.62320.922
Period202320242025MRQ
Shares, quarterly19.92319.92319.92320.3620.58520.62320.70320.82220.922
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY
Total Revenue64.4947.3231.6219.27
Cost of Goods Sold Incl. D&A18.6614.329.485.64
Gross Profit45.8332.9922.1413.63
Selling, General and Administrative Excl. Other80.9459.2936.8024.49
Research and Development13.537.734.493.02
Other Operating Expense0.000.000.000.00
Operating Income-35.11-26.30-14.65-10.86
Interest Expense-0.071.320.76
Unusual Expense0.5914.190.121.05
Net Income Before Taxes-33.35-40.36-15.62-12.65
Income Taxes0.000.000.000.00
Consolidated Net Income-33.35-40.36-15.62-12.65
Net Income From Continuing Operations-33.35-40.36-15.62-12.65
Net Income-33.35-40.36-15.62-12.65
EPS (Recurring)-1.58-1.48-0.78-0.60
EPS (Basic, Before Extraordinaries)-1.61-1.96-0.78-0.64
EPS (Diluted)-1.61-1.96-0.78-0.64
EBITDA-30.75-23.09-12.46-9.22
Non-Operating Income (Expense)2.350.200.470.02
Other After Tax Adjustments0.000.000.000.00
Stock Option Compensation Expense3.211.000.750.45
Price To Sales Ratio6.116.23--
Gross Margin71.0669.7370.0370.71
Operating Margin-54.44-55.58-46.34-56.37
Net Margin-51.72-85.29-49.39-65.66
Shares Outstanding20.9220.6219.9219.92
Market Capitalization458.83458.83312.12-

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue16.1917.1816.7114.4211.7611.0110.138.72
Cost of Goods Sold Incl. D&A4.604.874.854.343.643.343.011.96
Gross Profit11.5912.3111.8510.088.127.677.126.77
Selling, General and Administrative Excl. Other19.1822.3420.8318.5815.7613.5411.4210.30
Research and Development3.173.393.753.221.521.411.581.17
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-7.60-10.04-8.98-8.50-7.64-5.86-4.29-3.54
Interest Expense----0.080.220.370.39
Unusual Expense0.000.590.000.001.0611.720.000.00
Net Income Before Taxes-7.05-10.15-8.38-7.77-8.73-19.20-4.66-3.79
Income Taxes0.000.000.000.000.000.000.000.00
Consolidated Net Income-7.05-10.15-8.38-7.77-8.73-19.20-4.66-3.79
Net Income From Continuing Operations-7.05-10.15-8.38-7.77-8.73-19.20-4.66-3.79
Net Income-7.05-10.15-8.38-7.77-8.73-19.20-4.66-3.79
EPS (Recurring)-0.34-0.47-0.41-0.38-0.39-0.54-0.23-0.19
EPS (Basic, Before Extraordinaries)-0.34-0.49-0.41-0.38-0.42-0.94-0.23-0.19
EPS (Diluted)-0.34-0.49-0.41-0.38-0.42-0.94-0.23-0.19
EBITDA-6.48-8.90-7.84-7.52-6.80-5.14-3.63-
Non-Operating Income (Expense)0.550.470.600.730.05-1.40-0.000.14
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense1.021.080.730.380.300.190.130.18
Price To Sales Ratio6.117.005.576.236.21---
Gross Margin71.5771.6670.9569.9069.0569.6970.3077.57
Operating Margin-46.92-58.43-53.72-58.96-65.00-53.23-42.38-40.53
Net Margin-43.53-59.11-50.15-53.91-74.25-174.30-46.01-43.46
Shares Outstanding20.9220.8220.7020.6220.5820.3619.9219.92
Market Capitalization458.83420.57300.01294.60255.52255.72--

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY
Cash & Short Term Investments124.3115.0432.81
Short Term Receivables8.275.124.69
Inventories21.5913.969.92
Other Current Assets3.001.000.42
Total Current Assets157.1635.1247.85
Net Property, Plant & Equipment12.647.555.75
Total Investments and Advances0.000.000.00
Intangible Assets0.100.400.70
Other Assets0.000.000.00
Total Assets169.9143.0854.29
Short Term Debt Incl. Current Port. of LT Debt0.060.050.04
Accounts Payable8.874.861.96
Other Current Liabilities5.262.742.28
Total Current Liabilities14.207.654.28
Long Term Debt14.9614.6814.42
Provision for Risks Charges0.000.000.00
Other Liabilities0.000.970.85
Total Liabilities29.1623.3019.56
Non-Equity Reserves0.000.000.00
Preferred Stock - Carrying Value0.0074.4774.47
Common Equity140.75-54.70-39.74
Total Shareholders Equity140.7519.7834.74
Accumulated Minority Interest0.000.000.00
Total Equity140.7519.7834.74
Total Liabilities & Stockholders Equity169.9143.0854.29
Book Value Per Share6.82-2.75-1.99
Tangible Book Value Per Share6.82-2.77-2.03
Full-Time Employees7556-
Price to Book Ratio3.872.11-
Return on Assets-37.90-32.08-
Return on Equity-50.28-57.30-
Return on Invested Capital-25.92-45.32-25.74
Quick Ratio9.552.778.85
Current Ratio11.074.5911.17

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY
Net Income-33.35-40.36-15.62-12.65
Depreciation4.363.212.201.64
Other Funds (Non Cash)4.0315.290.322.63
Funds from Operations-24.96-21.86-13.11-8.38
Extraordinary Item0.000.000.000.00
Changes in Working Capital-10.47-6.75-1.04-4.76
Cash from Operating Activities-35.43-28.61-14.14-13.14
Capital Expenditures-7.76-7.41-4.01-2.75
Net Assets From Acquisitions0.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.00
Purchase or Sale of Investments25.93-88.1917.98-26.23
Purchase of Investments-42.08-119.49-5.28-29.25
Sale Or Maturity of Investments68.0131.3023.263.02
Other Uses0.000.000.000.00
Other Sources0.000.000.000.00
Cash from Investing Activities18.17-95.6013.96-28.97
Cash Dividends Paid0.000.000.000.00
Change in Capital Stock-1.26144.960.0734.88
Repurchase of Common Pref Stock0.000.000.000.00
Sale of Common Pref Stock-1.26144.960.0734.88
Proceedsfrom Stock Options-2.23143.580.0034.88
Issuance or Reduction of Debt, Net0.000.000.009.85
Change in Long Term Debt0.000.000.009.85
Issuance of Long Term Debt15.000.000.0014.85
Reduction of Long Term Debt-15.000.000.00-5.00
Net Financing Active Other Cash Flow0.000.000.000.00
Other Financing Activities Uses0.000.000.000.00
Cash from Financing Activities-1.26144.960.0744.73
Net Change in Cash-18.5220.75-0.112.61
Free Cash Flow-43.19-36.02-18.16-15.89
Preferred Dividends (Cash Flow)-0.000.000.00
Deferred Taxes & Investment Tax Credit-0.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments92.3398.99108.54124.31137.2939.63
Short Term Receivables9.2910.8710.558.277.086.89
Inventories24.3822.9221.8321.5919.3617.08
Other Current Assets5.084.624.863.002.885.31
Total Current Assets131.08137.41145.78157.16166.6168.91
Net Property, Plant & Equipment13.8314.5714.5612.6410.988.67
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets0.010.000.030.100.170.25
Other Assets0.650.030.000.000.000.00
Total Assets145.57152.01160.36169.91177.7677.83
Short Term Debt Incl. Current Port. of LT Debt0.040.040.050.060.070.08
Accounts Payable4.565.935.928.878.886.04
Other Current Liabilities7.686.866.375.266.076.37
Total Current Liabilities12.2812.8312.3414.2015.0212.49
Long Term Debt14.8514.8114.9614.9614.8514.78
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities0.020.030.040.000.062.05
Total Liabilities27.1527.6827.3429.1629.9329.33
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.00126.70
Common Equity118.43124.33133.02140.75147.83-78.20
Total Shareholders Equity118.43124.33133.02140.75147.8348.50
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity118.43124.33133.02140.75147.8348.50
Total Liabilities & Stockholders Equity145.57152.01160.36169.91177.7677.83
Book Value Per Share5.665.976.426.827.18-3.84
Tangible Book Value Per Share5.665.976.426.827.17-3.85
Full-Time Employees---75--
Price to Book Ratio3.873.162.131.99-3.27-3.27
Return on Assets-20.63-30.49-40.46-37.90--
Return on Equity-25.05-40.54-52.52-50.28--
Return on Invested Capital-5.29-7.30-5.66-4.99-5.37-30.33
Quick Ratio8.698.9210.049.559.804.15
Current Ratio10.6810.7111.8111.0711.095.52

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-7.05-10.15-8.38-7.77-8.73-19.20
Depreciation1.121.131.130.980.840.72
Other Funds (Non Cash)1.181.590.730.531.2913.44
Funds from Operations-4.75-7.43-6.51-6.26-6.59-5.04
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-1.64-0.47-5.85-2.52-1.960.24
Cash from Operating Activities-6.39-7.90-12.36-8.78-8.55-4.80
Capital Expenditures-0.59-2.16-2.73-2.28-2.81-1.47
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments18.7222.60-0.39-15.00-69.628.66
Purchase of Investments0.000.00-18.17-23.91-75.11-0.42
Sale Or Maturity of Investments18.7222.6017.788.915.489.08
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities18.1320.44-3.12-17.28-72.447.19
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.210.420.10-2.00108.8718.29
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.210.420.10-2.00108.8718.29
Proceedsfrom Stock Options0.000.000.00-2.23107.8818.17
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.0015.000.000.000.000.00
Reduction of Long Term Debt0.00-15.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities0.210.420.10-2.00108.8718.29
Net Change in Cash11.9612.97-15.38-28.0627.8820.68
Free Cash Flow-6.98-10.06-15.09-11.06-11.37-6.26

Revenue breakdown

Surgical & Medical Instruments & Apparatus2024: 31.62M 2025: 47.32M
United States2024: 31.62M 2025: 47.32M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-306.17%0.7M11.4M115.62K
2026-10-156.24%0.7M11.4M115.61K
2026-09-305.53%0.6M11.4M115.98K
2026-09-153.68%0.4M11.4M121.36K
2026-08-312.62%0.3M11.5M122.01K
2026-08-142.30%0.3M11.5M122.40K
2026-07-311.92%0.2M11.3M112.45K
2026-07-151.87%0.2M11.2M107.92K
2026-06-301.75%0.2M11.2M102.60K
2026-06-152.32%0.3M11.2M96.54K
2026-05-292.59%0.3M11.2M95.99K
2026-05-153.07%0.3M11.2M89.92K
2026-04-304.35%0.4M10.0M88.72K
2026-04-154.75%0.5M10.0M85.87K
2026-03-313.82%0.4M10.3M78.08K
2026-03-133.00%0.3M10.3M60.95K
2026-02-272.71%0.3M10.2M52.38K
2026-02-132.58%0.3M10.2M55.81K
2026-01-303.11%0.3M9.7M57.72K
2026-01-152.94%0.3M9.7M58.61K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-058-KCurrent report2026-11-05SEC
2026-11-024Statement of changes in beneficial ownership of securities2026-10-30SEC
2026-10-088-KCurrent report2026-10-08SEC
2026-10-064Statement of changes in beneficial ownership of securities2026-10-05SEC
2026-10-064Statement of changes in beneficial ownership of securities2026-10-05SEC
2026-10-064Statement of changes in beneficial ownership of securities2026-10-05SEC
2026-10-064Statement of changes in beneficial ownership of securities2026-10-05SEC
2026-09-144Statement of changes in beneficial ownership of securities2026-09-14SEC
2026-09-14144Filing for proposed sale of securities under Rule 144.SEC
2026-08-284Statement of changes in beneficial ownership of securities2026-08-26SEC
2026-08-244Statement of changes in beneficial ownership of securities2026-08-20SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-14SEC
2026-08-17144Filing for proposed sale of securities under Rule 144.SEC
2026-08-13EFFECTEffectiveness filing by commission orderSEC
2026-08-103Initial statement of beneficial ownership of securities2026-08-06SEC
2026-08-108-KCurrent report2026-08-10SEC
2026-08-07S-3Registration statement for specified transactions by certain issuers including face-amount certificate companiesSEC
2026-08-07SCHEDULE 13D/ASEC
2026-08-074Statement of changes in beneficial ownership of securities2026-08-05SEC
2026-08-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-068-KCurrent report2026-08-06SEC
2026-08-06SCHEDULE 13G/ASEC
2026-08-054Statement of changes in beneficial ownership of securities2026-08-03SEC
2026-08-034Statement of changes in beneficial ownership of securities2026-07-30SEC
2026-07-29144Filing for proposed sale of securities under Rule 144.SEC
2026-06-294Statement of changes in beneficial ownership of securities2026-06-26SEC
2026-06-294Statement of changes in beneficial ownership of securities2026-06-26SEC
2026-06-294Statement of changes in beneficial ownership of securities2026-06-26SEC
2026-06-298-KCurrent report2026-06-26SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-0900187.71K1
2026-08003.79M10
2026-07001.12M2
2026-0600374.25K2
2026-050000
2026-040000
2026-0378.23K300
2026-020000
2026-010000
2025-12136.64K400
2025-110000

Institutional holders

Manager% owned
FMR LLC18.71%
BlackRock, Inc.3.08%
SECTORAL ASSET MANAGEMENT INC2.08%
VANGUARD CAPITAL MANAGEMENT LLC1.89%
TimesSquare Capital Management, LLC1.68%
KCM Capital Inc1.45%
GEODE CAPITAL MANAGEMENT, LLC1.34%
DRIEHAUS CAPITAL MANAGEMENT LLC1.22%
Roubaix Capital, LLC1.10%
Parkman Healthcare Partners LLC1.09%

Funds

Fund% owned
Select Medical Technology and Devices Portfolio4.55%
Fidelity Small Cap Growth Fund3.75%
Select Health Care Portfolio2.62%
Fidelity Balanced Fund2.23%
Fidelity Small Cap Growth K6 Fund1.87%
VANGUARD TOTAL STOCK MARKET INDEX FUND1.55%
Fidelity Advisor Health Care Fund1.50%
iShares Russell 2000 ETF1.28%
Avantis Emerging Markets Equity ETF0.69%
Fidelity Small Cap Index Fund0.55%

OakChart. SI. Cached 15 minutes.